GB8305940D0 - Cephalosporin derivatives - Google Patents

Cephalosporin derivatives

Info

Publication number
GB8305940D0
GB8305940D0 GB838305940A GB8305940A GB8305940D0 GB 8305940 D0 GB8305940 D0 GB 8305940D0 GB 838305940 A GB838305940 A GB 838305940A GB 8305940 A GB8305940 A GB 8305940A GB 8305940 D0 GB8305940 D0 GB 8305940D0
Authority
GB
United Kingdom
Prior art keywords
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB838305940A
Other versions
GB2116180B (en
GB2116180A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/354,851 external-priority patent/US4406899A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GB8305940D0 publication Critical patent/GB8305940D0/en
Publication of GB2116180A publication Critical patent/GB2116180A/en
Application granted granted Critical
Publication of GB2116180B publication Critical patent/GB2116180B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08305940A 1982-03-04 1983-03-03 Cephalosporin derivatives Expired GB2116180B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/354,851 US4406899A (en) 1982-03-04 1982-03-04 Cephalosporins
US35753482A 1982-03-12 1982-03-12

Publications (3)

Publication Number Publication Date
GB8305940D0 true GB8305940D0 (en) 1983-04-07
GB2116180A GB2116180A (en) 1983-09-21
GB2116180B GB2116180B (en) 1985-09-18

Family

ID=26998584

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08305940A Expired GB2116180B (en) 1982-03-04 1983-03-03 Cephalosporin derivatives

Country Status (29)

Country Link
KR (1) KR870001986B1 (en)
AT (2) AT382155B (en)
AU (1) AU562776B2 (en)
BE (1) BE896086A (en)
CA (1) CA1213882A (en)
CH (1) CH654313A5 (en)
CS (1) CS249512B2 (en)
DD (1) DD210280A5 (en)
DE (1) DE3307550A1 (en)
DK (1) DK156900C (en)
EG (1) EG15934A (en)
ES (2) ES520224A0 (en)
FI (1) FI74973C (en)
FR (1) FR2522659B1 (en)
GB (1) GB2116180B (en)
GR (1) GR77916B (en)
HU (1) HU193158B (en)
IE (1) IE56647B1 (en)
IL (1) IL68011A0 (en)
IT (1) IT1170307B (en)
LU (1) LU84674A1 (en)
MY (1) MY8700943A (en)
NL (2) NL193284C (en)
NZ (1) NZ203312A (en)
PH (1) PH18002A (en)
PT (1) PT76330B (en)
SE (1) SE453091B (en)
SU (1) SU1250173A3 (en)
YU (2) YU43822B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3409431A1 (en) * 1983-10-08 1985-04-18 Hoechst Ag, 6230 Frankfurt CEPHALOSPORINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
DE3404906A1 (en) * 1984-02-11 1985-08-14 Bayer Ag, 5090 Leverkusen 1-OXADETHIACEPHALOSPORINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE3419013A1 (en) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen NEW CEPHALOSPORINE AND METHOD FOR THEIR PRODUCTION
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
US4698336A (en) * 1985-01-30 1987-10-06 Eisai Co., Ltd. 3-(pyrrolidinio)methyl-3-cephem derivatives
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
CA1284994C (en) * 1985-08-05 1991-06-18 Murray Arthur Kaplan Cephalosporin salts and injectable compositions
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
EP0237735B1 (en) * 1986-03-17 1994-03-30 Fujisawa Pharmaceutical Co., Ltd. 3,7-Disubstituted-3-cephem compounds and process for production of the same
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DE69231815T2 (en) 1991-03-08 2001-09-27 Biochemie Ges.M.B.H., Kundl Process for the preparation of cephalosporins and intermediates in this process
YU81692A (en) * 1991-09-10 1995-03-27 Bristol-Myers Co. PROCEDURE FOR THE PRODUCTION OF CEPHALOSPORIN ANTIBIOTICS
IL103110A (en) * 1991-09-10 1997-04-15 Bristol Myers Squibb Co Anhydrous process for preparing cefepime dihydrochloride hydrate
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics
CN100543027C (en) * 2003-12-23 2009-09-23 桑多斯有限公司 Preparation is used for the method for the intermediate of synthetic cynnematin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2715385A1 (en) * 1976-04-14 1977-11-10 Takeda Chemical Industries Ltd CEPHALOSPORIN DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THEM
GB1591439A (en) * 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
AR229883A1 (en) * 1978-05-26 1983-12-30 Glaxo Group Ltd PROCEDURE FOR THE PREPARATION OF ANTIBIOTIC (6R, 7R) -7 - ((Z) -2- (2-AMINOTIAZOL-4-IL) -2- (2-CARBOXIPROP-2-OXIIMINO) -ACETAMIDO) -3- (1 -PIRIDINOMETIL) -CEF-3-EM-4-CARBOXYLATE
CH644867A5 (en) * 1978-10-27 1984-08-31 Glaxo Group Ltd CEPHEMIC CARBON ACIDS SUBSTITUTED IN THE 3- AND 7-POSITION.
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds

Also Published As

Publication number Publication date
AT382155B (en) 1987-01-26
ATA228285A (en) 1987-05-15
FI830689A0 (en) 1983-03-01
IT8347826A0 (en) 1983-03-01
NZ203312A (en) 1985-12-13
SE453091B (en) 1988-01-11
GR77916B (en) 1984-09-25
IE56647B1 (en) 1991-10-23
ATA76183A (en) 1986-06-15
PH18002A (en) 1985-02-28
DK86283A (en) 1983-09-05
EG15934A (en) 1987-10-30
FI74973C (en) 1988-04-11
NL8300755A (en) 1983-10-03
YU149685A (en) 1986-02-28
NL193284B (en) 1999-01-04
PT76330A (en) 1983-04-01
IL68011A0 (en) 1983-06-15
IE830455L (en) 1983-09-04
DK86283D0 (en) 1983-02-24
MY8700943A (en) 1987-12-31
NL193284C (en) 1999-05-06
YU52383A (en) 1986-02-28
IT1170307B (en) 1987-06-03
DE3307550C2 (en) 1988-11-24
NL990039I2 (en) 2000-04-03
ES526397A0 (en) 1985-09-16
ES8507557A1 (en) 1985-09-16
BE896086A (en) 1983-09-05
DK156900B (en) 1989-10-16
LU84674A1 (en) 1983-11-17
DD210280A5 (en) 1984-06-06
SE8301178D0 (en) 1983-03-03
CS249512B2 (en) 1987-03-12
YU44777B (en) 1991-02-28
DE3307550A1 (en) 1983-09-15
HU193158B (en) 1987-08-28
DK156900C (en) 1990-03-12
NL990039I1 (en) 2000-01-03
FR2522659B1 (en) 1986-10-24
AU562776B2 (en) 1987-06-18
SU1250173A3 (en) 1986-08-07
KR840004118A (en) 1984-10-06
FI830689L (en) 1983-09-05
CA1213882A (en) 1986-11-12
FI74973B (en) 1987-12-31
CH654313A5 (en) 1986-02-14
AU1130483A (en) 1983-09-08
ES8403919A1 (en) 1984-04-01
FR2522659A1 (en) 1983-09-09
YU43822B (en) 1989-12-31
SE8301178L (en) 1983-09-05
KR870001986B1 (en) 1987-10-24
AT384612B (en) 1987-12-10
GB2116180B (en) 1985-09-18
GB2116180A (en) 1983-09-21
PT76330B (en) 1986-02-04
ES520224A0 (en) 1984-04-01

Similar Documents

Publication Publication Date Title
GB2134522B (en) Cephalosporin derivatives
GB2117770B (en) Cephalosporin derivatives
GB8413152D0 (en) Cephalosporin derivatives
GB2116180B (en) Cephalosporin derivatives
GB8430073D0 (en) Cephalosporin derivatives
DE3368638D1 (en) Cephalosporin derivatives
ZA842692B (en) Indolylglycyl cephalosporin derivatives
DE3380813D1 (en) Cephalosporin derivatives
GB8409381D0 (en) Benzothienylglycyl cephalosporin derivatives
DE3379404D1 (en) Cephalosporin derivatives
ZA842693B (en) Benzothienylglycyl cephalosporin derivatives
DE3379464D1 (en) Cephalosporin derivatives
GB8409379D0 (en) Naphthylglycyl cephalosporin derivatives
ZA842696B (en) Naphthylglycyl cephalosporin derivatives
ZA831887B (en) Cephalosporin derivatives
PH19163A (en) Cephalosporin derivatives
IE822172L (en) Cephalosporin derivatives
IE822174L (en) Cephalosporin derivatives
IE822302L (en) Cephalosporin derivatives
IE822303L (en) Cephalosporin derivatives
IE822304L (en) Cephalosporin derivatives
IE821298L (en) Cephem derivatives
IE822600L (en) Cephalosporin
PH16811A (en) Cephalosporin
IE830759L (en) Cephalosporin derivatives

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20030302